Emily A. Madden, PhD

Emily A. Madden, PhD has a diverse range of work experience in various scientific roles. Emily A. is currently working as a Scientific Grant Writer at EpiCypher, Inc. since 2023. Prior to this, they served as a Postdoctoral Researcher at Washington University in St. Louis from 2021 to 2023, working in the Laboratory of Michael S. Diamond, M. D. Emily A.'sresearch focused on RNA secondary structure in alphaviruses. From 2015 to 2021, they worked as a Ph.D. Graduate Researcher at the University of North Carolina at Chapel Hill, where they conducted research on the impact and role of RNA secondary structure in alphaviruses replication and pathogenesis. Additionally, during their time at UNC Chapel Hill, they also worked as a Graduate Teaching Assistant, delivering lectures and teaching microbiology techniques. In 2020, they interned at Chiesi USA, Inc., where they gained hands-on experience in regulatory affairs. Emily A. also participated in a Sao Paulo School of Advanced Science in Arbovirology program at Faculdade de Medicina de São José do Rio Preto - FAMERP in 2017. Prior to their graduate studies, they gained research experience as an Undergraduate Student Researcher at Paumi Lab, optimizing assays for Alzheimer's Disease therapeutics, as well as in the Jerome Lab and Wattenberg Lab, where they worked on projects related to viral transgene expression and cellular ceramides, respectively. Overall, Emily A. Madden, PhD has a strong background in scientific research and teaching, with expertise in RNA structure, virology, and therapeutic development.

Emily A. Madden, PhD completed their education with a strong foundation in the sciences. Emily A. earned their Bachelor's Degree in Biochemistry and Molecular Biology from Centre College, where they studied from 2011 to 2015. Following their undergraduate studies, they went on to pursue a Doctor of Philosophy (PhD) in Microbiology and Immunology at the University of North Carolina at Chapel Hill. Emily A. successfully completed their PhD program from 2015 to 2021, specializing in the field of Microbiology and Immunology.